Antisense strategies for glycosylation engineering of Chinese hamster ovary (CHO) cells.
Novel glycoproteins, inaccessible by other techniques, can be obtained by metabolic engineering of the oligosaccharide biosynthesis pathway. Furthermore, alteration of cell-surface oligosaccharides can change the properties of receptors involved in cell-cell adhesion. Sialyl Lewis X (sLex) is a cell-surface oligosaccharide determinant which is specifically expressed on granulocytes and monocytes and which interacts with selectins to influence leukocyte trafficking, thrombosis, inflammation, and cancer. Antisense technology targeting fucosyltransferase VI (Fuc-TVI), an enzyme necessary for the synthesis of the sLex in engineered Chinese hamster ovary (CHO) cells, has reduced Fuc-TVI activity, sLex synthesis, and adhesion to endothelial cells. Antisense methodology to reduce targeted activity in oligosaccharide biosynthesis or other pathways is an important addition to CHO cell metabolic engineering capabilities.
Prati
E G
EG
Institute of Biotechnology, ETH Zürich, CH-8093 Zürich, Switzerland.
Scheidegger
P
P
Sburlati
A R
AR
Bailey
J E
JE
D000818:Animals; D015153:Blotting, Western; D016466:CHO Cells; D002448:Cell Adhesion; D006224:Cricetinae; D017931:DNA Primers; D016373:DNA, Antisense / Q000737:chemistry*; D005647:Fucosyltransferases / Q000378:metabolism; D006031:Glycosylation; D006801:Humans; D016256:Lewis X Antigen / Q000737:chemistry; D014471:Umbilical Veins / Q000378:metabolism
D017931:DNA Primers; D016373:DNA, Antisense; D016256:Lewis X Antigen; D005647:Fucosyltransferases